23andMe (ME) - 2024 Q2 - Earnings Call Transcript

23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Ian Cooney - Senior Director, IR Anne Wojcicki - Chief Executive Officer and Co-Founder Joseph Selsavage - Interim Chief Financial and Accounting Officer Jennifer Low - Head of Therapeutics Bill Richards - Head of Therapeutics Discovery Conference Call Participants Chad Wiatrowski - TD Cowen David Lebowitz - Citigroup Inc. Operator Hello, and welcome to 23andMe's Fiscal Year 2024 Second Quarter ...